Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1988 May 1;167(5):1616–1624. doi: 10.1084/jem.167.5.1616

Differential induction of H-2K versus H-2D class I major histocompatibility antigens by recombinant gamma interferon. Lack of Kk augmentation in a leukemia virus-induced tumor is due to a cis-dominant effect

PMCID: PMC2188948  PMID: 3130455

Abstract

T-T tumor hybrids were constructed between the AKR SL3 thymoma and an H- 2-distinguishable thymoma cell line. Hybrids were stimulated with IFN- gamma to determine whether the differential augmentation of H-2D vs. H- 2K class I antigen expression by AKR SL3 in response to IFN-gamma was due to effects cis or trans to the noninducible Kk gene. For each of a large number of hybrids tested, the expression of H-2Db, Kb, and Dk, but not Kk, was substantially enhanced by murine rIFN-gamma. These results suggested that the lack of induction of the Kk gene was due to an alteration cis to Kk rather than to the presence or absence of K region-specific, trans-acting negative or positive factors, respectively.

Full Text

The Full Text of this article is available as a PDF (502.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldacci P., Transy C., Cochet M., Penit C., Israel A., Kourilsky P. A trans-acting mechanism represses the expression of the major transplantation antigens in mouse hybrid thymoma cell lines. J Exp Med. 1986 Sep 1;164(3):677–694. doi: 10.1084/jem.164.3.677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Baldwin A. S., Jr, Sharp P. A. Binding of a nuclear factor to a regulatory sequence in the promoter of the mouse H-2Kb class I major histocompatibility gene. Mol Cell Biol. 1987 Jan;7(1):305–313. doi: 10.1128/mcb.7.1.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Festenstein H., Schmidt W. Variation in MHC antigenic profiles of tumor cells and its biological effects. Immunol Rev. 1981;60:85–127. doi: 10.1111/j.1600-065x.1981.tb00363.x. [DOI] [PubMed] [Google Scholar]
  4. Green W. R., Brown M. A. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. II. Altered gp70 display and production of noninfectious virus particles by an insusceptible variant tumor. Eur J Immunol. 1983 Nov;13(11):871–877. doi: 10.1002/eji.1830131103. [DOI] [PubMed] [Google Scholar]
  5. Green W. R. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen. J Immunol. 1980 Dec;125(6):2584–2590. [PubMed] [Google Scholar]
  6. Green W. R., Nowinski R. C., Henney C. S. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis. J Immunol. 1980 Aug;125(2):647–655. [PubMed] [Google Scholar]
  7. Green W. R., Nowinski R. C., Henney C. S. The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens. J Exp Med. 1979 Jul 1;150(1):51–66. doi: 10.1084/jem.150.1.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Green W. R., Phillips J. D. Differential induction of H-2K vs H-2D class I major histocompatibility complex antigen expression by murine recombinant interferon-gamma. J Immunol. 1986 Aug 1;137(3):814–818. [PubMed] [Google Scholar]
  9. Israel A., Kimura A., Fournier A., Fellous M., Kourilsky P. Interferon response sequence potentiates activity of an enhancer in the promoter region of a mouse H-2 gene. Nature. 1986 Aug 21;322(6081):743–746. doi: 10.1038/322743a0. [DOI] [PubMed] [Google Scholar]
  10. Klyczek K. K., Murasko D. M., Blank K. J. Interferon-gamma, interferon-alpha/beta, and tumor necrosis factor differentially affect major histocompatibility complex class I expression in murine leukemia virus-induced tumor cell lines. J Immunol. 1987 Oct 15;139(8):2641–2648. [PubMed] [Google Scholar]
  11. Korber B., Hood L., Stroynowski I. Regulation of murine class I genes by interferons is controlled by regions located both 5' and 3' to the transcription initiation site. Proc Natl Acad Sci U S A. 1987 May;84(10):3380–3384. doi: 10.1073/pnas.84.10.3380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Manjunath R., Graziano R. F., Green W. R. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors. J Immunol. 1986 Mar 15;136(6):2271–2279. [PubMed] [Google Scholar]
  13. Meruelo D., Kornreich R., Rossomando A., Pampeno C., Mellor A. L., Weiss E. H., Flavell R. A., Pellicer A. Murine leukemia virus sequences are encoded in the murine major histocompatibility complex. Proc Natl Acad Sci U S A. 1984 Mar;81(6):1804–1808. doi: 10.1073/pnas.81.6.1804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rossomando A., Meruelo D. Viral sequences are associated with many histocompatibility genes. Immunogenetics. 1986;23(4):233–245. doi: 10.1007/BF00373018. [DOI] [PubMed] [Google Scholar]
  15. Yoshie O., Schmidt H., Reddy E. S., Weissman S., Lengyel P. Mouse interferons enhance the accumulation of a human HLA RNA and protein in transfected mouse and hamster cells. J Biol Chem. 1982 Nov 25;257(22):13169–13172. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES